[P2] Poster Discussion 2 (Even Numbers)

[P-72] 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a Partial STING Agonist, Competes for Human STING Activation

^○BURCU TEMIZOZ^1,2, TAKAYUKI SHIBAHARA^2,3, KOU HIOKI¹, MICHELLE SUE JANN LEE⁵, NAZ SURUCU⁹, ERDAL SAG¹⁰, MASAHIRO YAMAMOTO⁴, CEVAYIR COBAN^5,11, MAYDA GURSEL¹², SEZA OZEN¹⁰, ETSUSHI KURODA¹³, ATSUSHI KUMANOGOH^3,6,7,8, KEN J ISHII^1,2,11 (1.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.Laboratory of Mockup Vaccine, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan, 3.Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan, 4.Department of Immunoparasitology, Division of Infectious Disease, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan, 5.Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 6.Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan, 7.Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Osaka, Japan, 8.Center for Infectious Diseases for Education and Research (CiDER), Osaka University, Suita, Osaka, Japan, 9.Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey, 10.Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, 11.International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan, 12.Izmir Biomedicine and Genome Center, Izmir, Turkey, 13.Department of Immunology, School of medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan)